Table 1.
Baseline clinical characteristics of the study population (N = 460)
| Variable | |
|---|---|
| Mean age, y | 58 ±7 |
| Male sex | 324 (70) |
| Mean BSA, kg/m2 | 2 ± 0.5 |
| Etiology for liver transplantation | |
| HCV | 187 (41) |
| Alcoholic cirrhosis | 122 (27) |
| NASH | 85 (18) |
| Others | 66 (14) |
| MELD score | 21 ± 3 |
| HTN | 161 (35) |
| DM | 114 (25) |
| Hyperlipidemia | 60 (13) |
| CAD | 33 (7.0) |
| Smoking history | 285 (62) |
| CKD | 62 (14) |
| Stroke | 9 (2.0) |
| Medications | |
| ASA | 70 (15) |
| β‐Blockers | 281 (61) |
| Statins | 29 (6.0) |
| ACEIs | 82 (18) |
| INR | 1.5 ± 0.5 |
| Total bilirubin, mg/dL | 6 ± 9 |
| Serum Na, mg/dL | 132 ± 6 |
| sCr, mg/dL | 1.5 ± 1.3 |
Abbreviations: ACEI, angiotensin‐converting enzyme inhibitor; ASA, acetylsalicylic acid (aspirin); BSA, body surface area; CAD, coronary artery disease; CKD, chronic kidney disease; DM, diabetes mellitus; HCV, hepatitis C virus; HTN, hypertension; INR, international normalized ratio; MELD, Model for End‐Stage Liver Disease; Na, sodium; NASH, nonalcoholic steatohepatitis; sCr, serum creatinine; SD, standard deviation.
Data are presented as n (%) or mean ± SD.